Asahi Kasei Pharma to Expand Lineup in Orthopedic Field, Boost Osteoporosis Market Share through Once-Yearly Formulation of Reclast

Asahi Kasei Pharma President Yutaka Shibata Asahi Kasei Pharma is expanding its lineup of products in the orthopedic field, focusing mainly on osteoporosis, in order to strengthen domestic earnings. In May, an extension of the administration period for Teribone (teriparatide)...read more